Evaluation of Clinical and Genetic Determinants of Treatment OutCome In EGFR Mutation Positive Advanced Lung Adenocarcinoma

• Egile Nagusiak: Vera Jokic (Egilea), Katarina Savic-Vujovic (Egilea), Jelena Spasic (Egilea), Zoran Bukumiric (Egilea), Mladen Marinkovic (Egilea), Davorin Radosavljevic (Egilea), Milena Cavic (Egilea)
• Formatua: Liburua
• Argitaratua: SAGE Publishing, 2022-08-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Background The aim of this research was to evaluate clinical and low-cost genetic determinants of treatment outcome in EGFR mutation positive advanced lung adenocarcinoma patients. Material and Methods EGFR mutation testing and EGFR 181946C>T genotyping were performed in 101 advanced lung adenoca...